BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 24761872)

  • 1. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
    Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC
    Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elevated Fas expression is related to increased apoptosis of circulating CD8(+)T cell in patients with hepatocellular carcinoma].
    Guo CL; Bi YM; Liu Z; Xu Y; Sun YX; Wang QC
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):125-129. PubMed ID: 29804379
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma Level of Interleukin-35 as an Independent Prognostic Indicator in Hepatocellular Carcinoma.
    Qiu X; Wang X; Song Y; Chen L
    Dig Dis Sci; 2016 Dec; 61(12):3513-3521. PubMed ID: 27699510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma.
    Yuen MF; Hughes RD; Heneghan MA; Langley PG; Norris S
    Cancer; 2001 Oct; 92(8):2136-41. PubMed ID: 11596030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
    Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
    Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
    J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency and FOXP3 expression of human CD8
    Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF
    Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD3
    Ivanova OK; Sharapova TN; Romanova EA; Soshnikova NV; Sashchenko LP; Yashin DV
    J Cell Biochem; 2017 Oct; 118(10):3359-3366. PubMed ID: 28294381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a FOXP3(+)CD3(+)CD56(+) population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma.
    Li X; Peng J; Pang Y; Yu S; Yu X; Chen P; Wang W; Han W; Zhang J; Yin Y; Zhang Y
    Sci Rep; 2015 Oct; 5():14757. PubMed ID: 26437631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer.
    Yoshikawa T; Saito H; Osaki T; Matsumoto S; Tsujitani S; Ikeguchi M
    J Surg Res; 2008 Aug; 148(2):143-51. PubMed ID: 18561948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct different sensitivity of Treg and Th17 cells to Fas-mediated apoptosis signaling in patients with acute coronary syndrome.
    Li Q; Wang Y; Wang Y; Zhou Q; Chen K; Wang YM; Wei W; Wang Y
    Int J Clin Exp Pathol; 2013; 6(2):297-307. PubMed ID: 23330016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.
    Tateyama M; Oyaizu N; McCloskey TW; Than S; Pahwa S
    Blood; 2000 Jul; 96(1):195-202. PubMed ID: 10891451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
    Strauss L; Bergmann C; Whiteside TL
    J Immunol; 2009 Feb; 182(3):1469-80. PubMed ID: 19155494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation.
    Contini P; Ghio M; Merlo A; Poggi A; Indiveri F; Puppo F
    J Immunol; 2005 Dec; 175(11):7244-54. PubMed ID: 16301629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
    Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
    Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells, especially ICOS
    Tu JF; Ding YH; Ying XH; Wu FZ; Zhou XM; Zhang DK; Zou H; Ji JS
    Sci Rep; 2016 Oct; 6():35056. PubMed ID: 27725696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship and clinical significance of TGF-beta1 expression with Treg cell infiltration in hepatocellular carcinoma.
    Lin GH; Wang J; Li SH; Wang J; Xu L; Li SP
    Chin J Cancer; 2010 Apr; 29(4):403-7. PubMed ID: 20346216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective depletion of FOXP3(high) cells by Fas-Fas-L-induced apoptosis occurs in CD4(+)CD25(+)-enriched populations during repeated expansion.
    Zhang W; Nair S; Danby R; Peniket A; Roberts DJ
    Cytotherapy; 2013 Oct; 15(10):1286-96. PubMed ID: 23993302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.